Vanta Bioscience (BSE 540729)₹21.99−1.87%Healthcare Research, Analytics & Technology
Vanta Bioscience is compared with the 5 closest in size in Healthcare Research, Analytics & Technology (11 companies in the industry). It has a P/E of 157.1 against a peer median of 30.8, and ROCE of 1.2% against a peer median of 5.6%, and latest-quarter sales growth of 347.1% against a peer median of 21.6%. By market cap it is #6 of 6 in this set.
As of · Peer set: 5 closest in size in Healthcare Research, Analytics & Technology
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TAKE | 192 | 15.6 | 19.0 | 16.5 | 0.00 | 0.0 | 54 | 11 | — | — | vs BSE 540729 |
| Novelix Pharmaceuticals | 180 | 41.9 | 10.1 | 8.0 | 0.09 | 0.0 | 132 | 3 | 20.6 | 441.2 | vs BSE 540729 |
| Bilcare | 175 | 11.9 | 6.0 | 1.7 | 3.15 | 0.0 | 733 | −17 | 21.6 | — | vs BSE 540729 |
| Jeevan Scientific Technology | 162 | 42.5 | 5.0 | 1.9 | 0.30 | 0.0 | 62 | 1 | 107.7 | — | vs BSE 540729 |
| Adeshwar Meditex | 24 | 19.8 | 5.2 | 3.3 | 0.16 | 0.0 | 56 | 1 | −30.4 | −60.0 | vs BSE 540729 |
| Vanta Bioscience | 16 | 157.1 | 1.2 | 0.7 | 1.79 | 0.0 | 2 | 0 | 347.1 | — | — |
| Peer median | 169 | 30.8 | 5.6 | 2.6 | 0.23 | 0.0 | 59 | 1 | 21.6 | 190.6 |
Listed companies closest to Vanta Bioscience in Healthcare Research, Analytics & Technology include TAKE, Novelix Pharmaceuticals, Bilcare, Jeevan Scientific Technology, Adeshwar Meditex.
TAKE, with a market cap of ₹192 Cr.
Vanta Bioscience trades at a P/E of 157.1; the median of its peer set is 30.8. A P/E above or below the median is a description, not a judgement on value.
Vanta Bioscience's return on capital employed is 1.2%, below the peer median of 5.6%.